[{"id":"f2ab9702-20d4-4343-9605-1fb981c172bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT02316509","created_at":"2021-01-18T10:58:38.003Z","updated_at":"2024-07-02T16:36:40.393Z","phase":"Phase 1","brief_title":"A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer","source_id_and_acronym":"NCT02316509","lead_sponsor":"Genentech, Inc.","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" ER positive • HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GDC-0927"],"overall_status":"Completed","enrollment":" Enrollment 43","initiation":"Initiation: 03/17/2015","start_date":" 03/17/2015","primary_txt":" Primary completion: 01/10/2020","primary_completion_date":" 01/10/2020","study_txt":" Completion: 01/10/2020","study_completion_date":" 01/10/2020","last_update_posted":"2020-10-05"}]